2 Biotechs Get the FDA's Thumbs-Up

Yesterday saw two special protocol assessments handed down by the FDA for a pair of critical phase 3 trials. Find out what this means for the companies involved and for investors by watching the following video. 

The biotech space can make or break investors overnight, and while Amarin might not disappear into thin air, the success of its new triglyceride lowering drug is key to the company's future success or failure. The company has huge potential, but don't invest a dollar before reading everything you need to know about Amarin. You can start now with top Fool.com analyst Max Macaluso's premium research report. Click here now to keep reading.

Brenton Flynn, Dave Williamson, and The Motley Fool have no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2062505, ~/Articles/ArticleHandler.aspx, 8/30/2014 12:31:17 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 15 hours ago Sponsored by:
DOW 17,098.45 18.88 0.11%
S&P 500 2,003.37 6.63 0.33%
NASD 4,580.27 22.58 0.50%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

8/29/2014 3:59 PM
AMRN $1.93 Up +0.01 +0.52%
Amarin Corp plc (A… CAPS Rating: ***
ARQL $1.32 Up +0.03 +2.33%
ArQule, Inc. CAPS Rating: ****
CELG $95.02 Up +0.32 +0.34%
Celgene CAPS Rating: *****
PPHM $1.65 Down +0.00 +0.00%
Peregrine Pharmace… CAPS Rating: *
THLD $4.16 Up +0.08 +1.96%
THRESHOLD PHARMACE… CAPS Rating: ****

Advertisement